Medical

NovoCure

$169.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.74 (-1.59%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NovoCure and other stocks, options, and ETFs commission-free!

About NVCR

NovoCure Limited Ordinary Shares, also called NovoCure, is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey. The listed name for NVCR is NovoCure Limited Ordinary Shares.

CEO
Asaf Danziger
Employees
782
Headquarters
St. Helier, Jersey
Founded
2000
Market Cap
17.27B
Price-Earnings Ratio
971.40
Dividend Yield
—
Average Volume
573.01K
High Today
$172.95
Low Today
$167.83
Open Price
$170.92
Volume
260.96K
52 Week High
$182.74
52 Week Low
$53.40

Collections

NVCR Earnings

-$0.07
-$0.02
$0.04
$0.09
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 25, Pre-Market

You May Also Like

DKNG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure